Article
Clinical nomogram using novel CT based radiomics predicts survival in non-small cell lung cancer patients treated with SBRT
2022-06-22
Abstract excerpt
<h4>Introduction</h4> Improved survival prediction and risk stratification in non-small cell lung cancer (NSCLC) would lead to better prognosis counseling, adjuvant therapy selection, and clinical trial design. We propose the PHOM (persistent homology) score, the radiomic quantification of solid tumor topology, as a solution. <h4>Methods</h4> Patients diagnosed with stage I or II NSCLC primarily treated with stere...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- f17bd6fd-d7de-518c-8aa8-89b75b8e904f
- DOI
- 10.1101/2022.06.21.22276718
